Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Umeå University · Glostrup Hospital · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,571
total citations
- FWCI
- 117.57
- Percentile
- 100%
- References
- 31
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Atenolol
- Medicine
- Losartan
- Internal medicine
- Blood pressure
- Myocardial infarction
- Clinical endpoint
- Diabetes mellitus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.